Israel
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
4.80 |
Feb. 5, 2025 | USD 5.12 | -0.25% |
|
Israel |
|
2 |
3.27 |
Feb. 5, 2025 | USD 2.38 | 4.02% |
|
Israel |
|
3 |
3.13 |
Feb. 5, 2025 | USD 19.31 | 2.67% |
|
Israel |
|
4 |
2.63 |
Feb. 5, 2025 | USD 17.63 | 0.27% |
|
Israel |
|
5 |
2.36 |
Feb. 5, 2025 | USD 0.47 | 2.02% |
|
Israel |
|
6 |
2.03 |
Feb. 5, 2025 | USD 15.67 | -0.43% |
|
Israel |
|
7 |
1.66 |
Feb. 5, 2025 | USD 6.96 | 3.55% |
|
Israel |
|
8 |
1.56 |
Feb. 5, 2025 | USD 1.01 | -2.91% |
|
Israel |
|
9 |
1.50 |
Feb. 5, 2025 | USD 0.08 | 0.74% |
|
Israel |
|
10 |
1.38 |
Feb. 5, 2025 | USD 20.80 | 2.06% |
|
Israel |
|
11 |
1.07 |
Feb. 5, 2025 | USD 3.98 | 1.67% |
|
Israel |
|
12 |
1.05 |
Feb. 5, 2025 | USD 0.07 | 0.74% |
|
Israel |
|
13 |
0.96 |
Feb. 5, 2025 | USD 5.23 | 1.06% |
|
Israel |
|
14 |
0.96 |
Feb. 5, 2025 | USD 0.01 | -3.84% |
|
Israel |
|
15 |
0.87 |
Feb. 5, 2025 | USD 0.24 | 0.85% |
|
Israel |
|
16 |
0.81 |
Feb. 5, 2025 | USD 1.51 | 0.55% |
|
Israel |
|
17 |
0.81 |
Feb. 5, 2025 | USD 0.11 | 3.21% |
|
Israel |
|
18 |
0.70 |
Feb. 5, 2025 | USD 0.10 | 14.21% |
|
Israel |
|
19 |
0.62 |
Feb. 5, 2025 | USD 2.77 | 0.01% |
|
Israel |
|
20 |
0.38 |
Feb. 5, 2025 | USD 0.09 | 0.74% |
|
Israel |
|
21 |
0.25 |
Feb. 5, 2025 | USD 0.02 | -4.22% |
|
Israel |
The Healthcare company in Israel with the highest Price to Book Ratio (P/B) is BrainsWay Ltd. (Tel Aviv Stock Exchange: BWAY.TA) at 4.80.
The Healthcare company in Israel with the lowest Price to Book Ratio (P/B) is Purple Biotech Ltd. (Tel Aviv Stock Exchange: PPBT.TA) at 0.25.
The top 10 Healthcare companies in Israel by Price to Book Ratio (P/B) are BrainsWay Ltd., Compugen Ltd., Delta Israel Brands Ltd, Teva Pharmaceutical Industries Limited, Novolog (Pharm-Up 1966) Ltd, Victory Supermarket Chain Ltd, Kamada Ltd., Matricelf Ltd, Bio-View Ltd and Ilex Medical Ltd.
The bottom 10 Healthcare companies in Israel by Price to Book Ratio (P/B) are Purple Biotech Ltd., Human Xtensions Ltd., SHL Telemedicine Ltd., Allmed Solutions Ltd, Tikun Olam-Cannbit Pharmaceuticals Ltd, Evogene Ltd., BATM Advanced Communications Ltd., BioLineRx Ltd., Aran Research & Development (1982) Ltd. and Erika B-Cure Laser Ltd.